Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings JAMA Netw Open. 2021 Apr 1;4(4):e218559. doi: 10.1001/jamanetworkopen.2021.8559. Lori C Sakoda  1   2 , M Patricia Rivera  3   4 , et al.

Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non-Small Cell Lung Cancer in U.S. Community Medical Centers Oncologist. 2021 Apr 6. doi: 10.1002/onco.13779. Online ahead of print.

Healthcare Access, Utilization, and Preventive Health Behaviors by Eligibility for Lung Cancer Screening J Cancer Educ. 2021 Apr;36(2):330-337. doi: 10.1007/s13187-019-01634-y. Eric A Miller  1 , Paul F Pinsky  2

Video-Based Education in Lung Cancer Screening J Cancer Educ. 2021 Apr;36(2):305-309. doi: 10.1007/s13187-019-01629-9. Juan Alban  1 , Luis-Felipe Alban  2 , Andrew Clayburn  3 , Amit Khanal  4 , Lawrence Feldman  5

A Comparison of Web-Based Cancer Risk Calculators That Inform Shared Decision-making for Lung Cancer Screening J Gen Intern Med. 2021 Apr 9. doi: 10.1007/s11606-021-06754-0. Online ahead of print. Frederick R Kates  1 , Ryan Romero  2 , Daniel Jones 3 , Jacqueline Egelfeld 4 , Santanu Datta  5

Propensity-score-matching analysis to compare efficacy and safety between 16-gauge and 18-gauge needle in ultrasound-guided biopsy for peripheral pulmonary lesions BMC Cancer. 2021 Apr 9;21(1):390. doi: 10.1186/s12885-021-08126-7. Weijun Huang #  1   2 , Jieyi Ye #  2 , Yide Qiu  2 , Weiwei Peng  2 , Ninghui Lan  2 , Weizhen Cui  2 , Ting Huang  2 , Yinghui Ou  2 , Yingjia Li  3

Patient Adherence in an Academic Medical Center’s Low-dose Computed Tomography Screening Program Am J Clin Oncol. 2021 Apr 1. doi: 10.1097/COC.0000000000000817. Online ahead of print. Keith D Mortman  1 , Joseph Devlin, Brian Giang, Ryan Mortman, Andrew D Sparks, Michael A Napolitano

Molecular Biomarker and Program Death-Ligand 1 Expression Testing in Patients with Advanced Stage Non-Small Cell Lung Cancer Across North Carolina Community Hospitals Chest. 2021 Apr 19;S0012-3692(21)00702-9. doi: 10.1016/j.chest.2021.04.014. Online ahead of print. M Patricia Rivera  1 , Marjory Charlot  2 , Danielle D Durham  3 , et al.

Predicting Lymph Node Metastasis in Non-Small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models Chest. 2021 Apr 28;S0012-3692(21)00856-4. doi: 10.1016/j.chest.2021.04.048. Online ahead of print. Gabriela Martinez-Zayas  1 , Francisco A Almeida  2 , Lonny Yarmus  3 , et al.

A Retrospective Multi-Site Academic Center Analysis of Pneumothorax and Associated Risk Factors after CT-Guided Percutaneous Lung Biopsy Lung. 2021 Apr 19. doi: 10.1007/s00408-021-00445-7. Online ahead of print. Esther Rong  1 , David A Hirschl  2 , Benjamin Zalta  2 , Anna Shmukler  2   3 , Steven Krausz  2 , Jeffrey M Levsky  2 , Juan Lin  4 , Linda B Haramati  2 , Arash Gohari  2

Augmented Fluoroscopy: A New and Novel Navigation Platform for Peripheral Bronchoscopy J Bronchology Interv Pulmonol. 2021 Apr 1;28(2):116-123. doi: 10.1097/LBR.0000000000000722. Joseph Cicenia  1 , Krish Bhadra  2 , Sonali Sethi  1 , Daniel A Nader  3 , Patrick Whitten  4 , Douglas Kyle Hogarth  5

EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non-Small Cell Lung Cancer Cancers (Basel). 2021 Apr 25;13(9):2084. doi: 10.3390/cancers13092084. Roberto Martin-Deleon  1 , Cristina Teixido  2   3 , et al.

Combination of nitrous oxide and the modified inflation-deflation method for identifying the intersegmental plane in segmentectomy: A randomized controlled trial Thorac Cancer. 2021 May;12(9):1398-1406. doi: 10.1111/1759-7714.13919. Epub 2021 Apr 4. Wenjing Yang #  1 , Zicheng Liu #  2 , Chun Yang  1 , et al. Shijiang Liu  1 , Minna Guo  1 , Wei Wen  2 , Jun Wang  2 , Cunming Liu  1 , Quan Zhu  2

Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma J Cancer. 2021 Apr 2;12(11):3222-3229. doi: 10.7150/jca.51405. eCollection 2021. Yan Li  1   2 , Yan Tan  3 , Song Hu  1 , Jun Xie  1 , Zhantao Yan  3 , Xian Zhang  1 , Yun Zong  1, Han Han-Zhang  4 , Qing Li  3 , Chong Li  1

Impact of the Extent of Lymph Node Dissection on Precise Staging and Survival in Clinical I-II Pure-Solid Lung Cancer Undergoing Lobectomy J Natl Compr Canc Netw. 2021 Jan 28;19(4):393-402. doi: 10.6004/jnccn.2020.7635. Print 2021 Apr. Donglai Chen 1, Yiming Mao 2 , Junmiao Wen  3  4 , et al.

Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry Lung. 2021 Apr 28. doi: 10.1007/s00408-021-00447-5. Online ahead of print. Andrew T Arndt  1 , Alessandro Brunelli  2 , Silvia Cicconi  3 , et al.

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program Eur J Cancer. 2021 May;149:235-248. doi: 10.1016/j.ejca.2021.02.038. Epub 2021 Apr 2. Arsela Prelaj  1 , Achille Bottiglieri  2 , Claudia Proto  2 , et al.

Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer Oncologist. 2021 Apr 12. doi: 10.1002/onco.13787. Online ahead of print. Monica Peravali  1 , Jaeil Ahn  2 , Kevin Chen  3 , Suman Rao  3 , Irina Veytsman  1 , Stephen V Liu  4 , Chul Kim  4

A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer Clin Cancer Res. 2021 Apr 5. doi: 10.1158/1078-0432.CCR-20-4792. Online ahead of print. Michael R Shafique  1 , Terrence L Fisher  2 , Elizabeth E Evans  3 , et al.

Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices Sci Rep. 2021 Apr 28;11(1):9222. doi: 10.1038/s41598-021-88453-8. Vamsidhar Velcheti  1 , Xiaohan Hu  2 , Bilal Piperdi  2   3 , Thomas Burke  2

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50 J Clin Oncol. 2021 Apr 19;JCO2100174. doi: 10.1200/JCO.21.00174. Online ahead of print. Martin Reck  1 , Delvys Rodríguez-Abreu  2 , Andrew G Robinson  3 , et al.

Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial Eur J Cancer. 2021 May;149:14-22. doi: 10.1016/j.ejca.2021.02.019. Epub 2021 Apr 1. Kentaro Tanaka  1 , Hajime Asahina  2 , Junji Kishimoto  3 , et al.

Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: Protocol-Specified Final Analysis From KEYNOTE-189 Ann Oncol. 2021 Apr 21;S0923-7534(21)01146-7. doi: 10.1016/j.annonc.2021.04.008. Online ahead of print. Authors Speranza  7 , F De Angelis  7 , M Dómine  8 , et al.

Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy J Thorac Oncol. 2021 Apr 20;S1556-0864(21)02109-2. doi: 10.1016/j.jtho.2021.03.029. Online ahead of print. Apar Pataer  1 , Annikka Weissferdt  2 , Ara A Vaporciyan  3 , et al.

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC Front Oncol. 2021 Apr 16;11:671228. doi: 10.3389/fonc.2021.671228. eCollection 2021. Ya Chen  1 , Zhengyu Yang  1 , et al.

Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study Ann Transl Med. 2021 Apr;9(8):648. doi: 10.21037/atm-20-6497. Montse Alemany  1 , Marta Domènech  2 , Andreas A Argyriou  3 , et al. Noelia Vilariño  1   2 , Carles Majós  1   4 , Pablo Naval-Baudin  4 , Anna Lucas  1 , Ramón Palmero  2 ,

Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry J Neurooncol. 2021 Apr;152(2):299-311. doi: 10.1007/s11060-021-03698-7. Epub 2021 Jan 22. Anthony L Asher  1 , Mohammed Ali Alvi  2 , et al.

Systemic effect of radiotherapy before or after nivolumab in lung cancer: an observational, retrospective, multicenter study Tumori. 2021 Apr 4;3008916211004733. doi: 10.1177/03008916211004733. Online ahead of print. Maria Bassanelli  1 , Biagio Ricciuti  2 , Diana Giannarelli  3 , et al.

Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors Br J Cancer. 2021 Apr 7. doi: 10.1038/s41416-021-01375-0. Online ahead of print. Wei Mu  1 , Evangelia Katsoulakis  2 , Christopher J Whelan  1 , Kenneth L Gage  3 , Matthew B Schabath  4   5 , Robert J Gillies  6

Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapy Radiother Oncol. 2021 Apr 21;160:25-31. doi: 10.1016/j.radonc.2021.04.010. Online ahead of print. Jacob S Parzen  1 , Muayad F Almahariq  2 , Thomas J Quinn  1 , Zaid A Siddiqui  3 , Andrew B Thompson  1 , Thomas Guerrero  1 , Kuei Lee  1 , Craig Stevens  1 , Inga S Grills  1

The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy J Thorac Oncol. 2021 Apr 3;S1556-0864(21)02074-8. doi: 10.1016/j.jtho.2021.03.019. Online ahead of print. Karin Lindberg  1 , Vitali Grozman  2 , Kristin Karlsson  3 , et al.

Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys. 2021 Apr 20;S0360-3016(21)00375-8. doi: 10.1016/j.ijrobp.2021.04.014. Online ahead of print. Yudai Tateishi  1 , Atsuya Takeda  2 , Nobuyuki Horita  3 , Yuichiro Tsurugai  4 , Takahisa Eriguchi  5 , Yuichi Kibe  6 , Naoko Sanuki  7 , Takeshi Kaneko  8

Radiation and Modulation of the Tumor Immune Microenvironment in Non-Small Cell Lung Cancer Semin Radiat Oncol. 2021 Apr;31(2):133-139. doi: 10.1016/j.semradonc.2020.11.010. Peter H Goff  1 , Jing Zeng  2 , Ramesh Rengan  2 , Stephanie K Schaub  2

Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations Cancer Manag Res. 2021 Apr 15;13:3293-3301. doi: 10.2147/CMAR.S299563. eCollection 2021. Yingyun Zhang  1   2 , Wei Wang  1   2 , Xuedong Xu  1   2 , Yankang Li  1   3 , Hui Zhang  4 , Jianbin Li  1   2 , Zhenxiang Li  1

Efficacy and Safety of Niraparib as Maintenance Treatment in Patients with Extensive-Stage Small Cell Lung Cancer after First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study J Thorac Oncol. 2021 Apr 26;S1556-0864(21)02111-0. doi: 10.1016/j.jtho.2021.04.001. Online ahead of print. Xinghao Ai  1 , Yueyin Pan  2 , Jianhua Shi  3 , et al.

Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function BMC Pulm Med. 2021 Apr 15;21(1):122. doi: 10.1186/s12890-021-01489-4. Xiyue Zhang  1 , Wei Li  1 , Chunyan Li  1 , Jie Zhang  2 , Zhenzhong Su  3

Promising Role of Circulating Tumor Cells in the Management of SCLC Cancers (Basel). 2021 Apr 22;13(9):2029. doi: 10.3390/cancers13092029. Antonella De Luca  1 , Marianna Gallo  1 , Claudia Esposito  1 , Alessandro Morabito  2 , Nicola Normanno  1

Symptom Treatment Preferences of Cancer Survivors: Does Fatigue Level Make a Difference? Cancer Nurs. 2021 Apr 21. doi: 10.1097/NCC.0000000000000941. Online ahead of print. Ellen Krueger  1 , Ekin Secinti, Catherine E Mosher, Patrick V Stutz, Andrea A Cohee, Shelley A Johns

“Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study” BMC Cancer. 2021 Apr 1;21(1):352. doi: 10.1186/s12885-021-08084-0. Brett C Bade  1 , Geliang Gan  2 , Fangyong Li  2 , Lingeng Lu  3 , Lynn Tanoue  4 , Gerard A Silvestri  5 , Melinda L Irwin  3

Distress experienced by lung cancer patients and their family caregivers in the first year of their cancer journey Palliat Support Care. 2021 Apr 26;1-7. doi: 10.1017/S1478951521000377. Online ahead of print. Michèle Aubin  1   2   3 , Lucie Vézina  1 , René Verreault  3 , et al.

Functional Decline as an Indicator of Ill-Health: A Retrospective Case Study of the Process Leading to Lung Cancer J Multidiscip Healthc. 2021 Apr 27;14:919-927. doi: 10.2147/JMDH.S295498. eCollection 2021. Lesleigh Kowalski  1

Incidence and Risk Factors of Pneumonitis in Patients with Non-Small Cell Lung Cancer: An Observational Analysis of Real-World Data Oncol Ther. 2021 Apr 28. doi: 10.1007/s40487-021-00150-8. Online ahead of print. Jerzy E Tyczynski  1 , Ravi Potluri  2 , Ryan Kilpatrick  3 , Debasish Mazumder  4 , Anirban Ghosh  4 , Alexander Liede  3   5

Determining Risk Factors Associated with Depression and Anxiety in Young Lung Cancer Patients: A Novel Optimization Algorithm Medicina (Kaunas). 2021 Apr 1;57(4):340. doi: 10.3390/medicina57040340 Yu-Wei Fang  1   2 , Chieh-Yu Liu  3   4

Role of myokines and osteokines in cancer cachexia Exp Biol Med (Maywood). 2021 Apr 25;15353702211009213. doi: 10.1177/15353702211009213. Online ahead of print. Fabrizio Pin  1 , Lynda F Bonewald  1   2   3 , Andrea Bonetto  1   2   3   4   5

Variation in Use of High-Cost Technologies for Palliative Radiation Therapy by Radiation Oncologists J Natl Compr Canc Netw. 2021 Feb 12;19(4):421-431. doi: 10.6004/jnccn.2020.7633. Print 2021 Apr. Aileen B Chen  1 , Jiangong Niu  1 , Angel M Cronin  2 , Ya-Chen Tina Shih  1 , Sharon Giordano  1 , Deborah Schrag  2

Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer Am J Clin Oncol. 2021 Apr 19. doi: 10.1097/COC.0000000000000814. Online ahead of print. Rhonda L Bitting  1 , Janet A Tooze, Scott Isom, et al.

A Combined Phytochemistry and Network Pharmacology Approach to Reveal Potential Anti-NSCLC Effective Substances and Mechanisms in Marsdenia tenacissima (Roxb.) Moon (Stem) Front Pharmacol. 2021 Apr 29;12:518406. doi: 10.3389/fphar.2021.518406. eCollection 2021. Pei Liu  1   2 , Dong-Wei Xu  1   2 , Run-Tian Li  1   2 , et al.

Clinical observation of Yiqi Qingdu prescription on the treatment of intermediate-stage and advanced non-small-cell lung cancer J Tradit Chin Med. 2021 Apr;41(2):308-315. Qijun Liang  1 , Xiaoling Tang  2 , Jiong Yu  3 , Monian Xiong  3 , Huifang Zhu  4 , Linkai Xiong  5 , Ru Zeng  4 , Peiwen Yu  4    

Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism Cancer Immunol Immunother. 2021 Apr 20. doi: 10.1007/s00262-021-02927-2. Online ahead of print. Hui-Ming Chen  1   2   3 , Linus Sun  4 , Ping-Ying Pan  1   2   3 , Lu-Hai Wang  5 , Shu-Hsia Chen  6   7   8   9

The Use of Traditional Chinese Medicine in Relieving EGFR-TKI-Associated Diarrhea Based on Network Pharmacology and Data Mining Evid Based Complement Alternat Med. 2021 Apr 1;2021:5530898. doi: 10.1155/2021/5530898. eCollection 2021. Shuaihang Hu  1   2 , Wenchao Dan  1   2 , Jinlei Liu  1   2 , Peng Ha  3 , Tong Zhou  1 , Xinyuan Guo  4 , Wei Hou  1

Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California  Cancer Epidemiol Biomarkers Prev. 2021 Apr 20;cebp.1528.2020. doi: 10.1158/1055-9965.EPI-20-1528. Online ahead of print. Heidy N Medina  1 , Karen E Callahan  2 , Cyllene R Morris  3 , Caroline A Thompson  4 , Adugna Siweya  2 , Paulo S Pinheiro  5

What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist? Clin Oncol (R Coll Radiol). 2021 Apr 5;S0936-6555(21)00103-5. doi: 10.1016/j.clon.2021.03.012. Online ahead of print. M S Andres  1 , J Pan  2 , A R Lyon  3

Beliefs About the Health Effects of Smoking Among Adults in the United States Health Educ Behav. 2021 Apr 17;10901981211004136. doi: 10.1177/10901981211004136. Online ahead of print. Sarah D Mills  1  2 , Christopher A Wiesen  3

Population-based estimates of survival among elderly patients with brain metastases Neuro Oncol. 2021 Apr 12;23(4):661-676. doi: 10.1093/neuonc/noaa233.Nayan Lamba  1 , Rachel Brigell Kearney  1 , Paul J Catalano  2 , Michael J Hassett  3 , Patrick Y Wen  4 , Daphne A Haas-Kogan  1 , Ayal A Aizer  1

Experiences of Inuit in Canada who travel from remote settings for cancer care and impacts on decision making BMC Health Serv Res. 2021 Apr 13;21(1):328. doi: 10.1186/s12913-021-06303-9. Janet Jull  1 , Amanda J Sheppard  2 , et al. .

Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment Curr Med Res Opin. 2021 Apr;37(4):643-653. doi: 10.1080/03007995.2021.1888707. Epub 2021 Mar 1. Sarah Janse  1 , Ellen Janssen  2 , Tanya Huwig  1 , Upal Basu Roy  3 , Andrea Ferris  3 , Carolyn J Presley  4 , John F P Bridges  1   5

Dynamic Management of Lung Cancer Care During Surging COVID-19 Front Surg. 2021 Apr 7;8:663364. doi: 10.3389/fsurg.2021.663364. eCollection 2021. Annie Wang  1 , Stephanie H Chang  2 , Eric J Kim  3 , Jamie L Bessich  4 , Joshua K Sabari  4 , Benjamin Cooper  5 , Travis C Geraci  2 , Robert J Cerfolio  2

Understanding the patient journey to diagnosis of lung cancer BMC Cancer. 2021 Apr 14;21(1):402. doi: 10.1186/s12885-021-08067-1. Yichen Zhang  1 , Michael J Simoff  2 , David Ost  3 , Oliver J Wagner  4 , James Lavin  4 , Beth Nauman  5 , Mei-Chin Hsieh  6 , Xiao-Cheng Wu  6 , Brian Pettiford 7, Lizheng Shi  1

Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For J Thorac Oncol. 2021 Apr;16(4):546-571. doi: 10.1016/j.jtho.2020.12.014. Epub 2021 Jan 7. Michele Carbone  1 , John Lednicky  2 , Shu-Yuan Xiao  3 , Mario Venditti  4 , Enrico Bucci  5